Tevis Investment Management Vertex Pharmaceuticals Inc Transaction History
Tevis Investment Management
- $134 Million
- Q3 2024
A detailed history of Tevis Investment Management transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Tevis Investment Management holds 1,042 shares of VRTX stock, worth $515,383. This represents 0.36% of its overall portfolio holdings.
Number of Shares
1,042
Previous 851
22.44%
Holding current value
$515,383
Previous $398,000
21.61%
% of portfolio
0.36%
Previous 0.32%
Shares
5 transactions
Others Institutions Holding VRTX
# of Institutions
1,721Shares Held
227MCall Options Held
1.21MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA26.8MShares$13.3 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$11.5 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.5 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.7MShares$5.8 Billion0.24% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$4.45 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $127B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...